The principal research question is to assess the number of patients alive in the re-irradiation arm at 9 months post-start of treatment. Overall survival will be defined as the time from randomisation to the date of death from any cause. OS rates in the chemotherapy arm will also be assessed for calibration purposes only and not for direct statistical comparison.